Sectra (STO:SECTB) and Leica Biosystems announced that they formed a partnership to collaborate in an effort to win FDA clearance for an integrated clinical pathology solution. The companies said their goal is to address the clinical needs of enterprise-level customers, including academic medical centers, clinical research organizations and large hospital networks. They have already submitted an […]
These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal […]
Sectra (STO:SECTB) said today that it’s establishing a direct sales force in Canada for its medical imaging and cybersecurity offerings. The Swedish company said the move will allow it to focus on the specific needs of the market north of the border, from a base in Toronto that’s expected to go live before September. “To expand in […]
Sectra (OMX:SECTB) said it acquired RxEye AB and its cloud-based medical imaging platform for an undisclosed amount on Dec. 30, 2015. The RxEye Cloud service is used to remotely view images by more than 2,000 users in European radiology, nuclear medicine and pathology departments and teleradiology services companies, Linköping, Sweden-based Sectra said. RxEye, which employs 6 workers, posted sales of about […]
Microsoft‘s (NSDQ:MSFT) Kinect, originally developed as a motion sensor for its Xbox gaming systems, is helping researchers refine X-ray imaging through analysis of body part thickness, motion and positioning, researchers said today, and with the use of the best wireless router
Globus Medical filed for an initial public offering yesterday, saying it’s planning a reverse split of its existing stock just before the IPO launches.
The Audubon, Pa.-based orthopedic device maker, which ran afoul of the FDA last month, said it hopes to trade under the "GMED" ticker on the New York Stock Exchange.
Shares of orthopedic device makers are up this morning after bellwether Biomet Inc. reported preliminary sales numbers indicating 3.8% growth for its fiscal second quarter.
George LeMaitre, chairman & CEO of the vascular device firm that bears his name, told analysts on a conference call that LeMaitre Vascular (NSDQ:LMAT) has two new products it expects to launch during the fourth quarter.
The Burlington, Mass.-based company is in the last stages of post-approval trials for the devices – the UnBalloon and an over-the-wire device used to excise heart valves – LeMaitre said during a call to discuss LMAT’s third-quarter numbers.
Electromed Inc. (NSDQ:ELMD) was just shy of raising its profits during fiscal 2011, on the strength its fourth-quarter numbers.
The New Prague, Minn.-based airway clearance device firm, which took itself public a year ago, posted profits of $165,000, or 2 cents per share, on sales of $5.0 million during the three months ended June 30. That compares with net income of $71,000, or 1 cent per share, on sales of $3.6 million during the same period last year.